Posts Tagged: Galderma Labs

Analyzing obviousness and anticipation challenges to claims directed to an isolated component of a prior art mixture

Based on the governing Federal Circuit case law, where the patent claim at issue is directed to a specific component (such as a specific enantiomer) of a …
By Theodore Chiacchio
4 years ago 1

Federal Circuit Review – Issue 2 – 12-18-2013

In this issue of the Federal Circuit Review: (1) Court Reverses Nonobviousness Holding by District Court in Hatch-Waxman Case; (2) Statute Covers Costs for Faithful and Complete Duplication of …